Health news
Chronic migraine affects an estimated 1.4%-2.2% of people worldwide, with a preponderance of cases in women (1.7%-4.0%) compared to men (0.6%-0.7%). Each year, approximately 3% of individuals with episodic migraine progress to chronic migraine.1 In…
Depression and attentional alterations are recurrent among patients with relapsing-remitting multiple sclerosis (RRMS), according to study results presented at the 2021 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC), held October 25-28, 2021…
International consensus recommendations on the use of standardized magnetic resonance imaging (MRI) in multiple sclerosis (MS) developed by the Magnetic Resonance Imaging in MS (MAGNIMS) group, the Consortium of Multiple Sclerosis Centers (CMSC), and the…
Urate-elevating inosine treatment had no beneficial effect on the rate of clinical disease progression among patients with newly diagnosed Parkinson disease (PD), according to study results published in JAMA. Prior studies have suggested that urate,…
The American Society for Stereotactic and Functional Neurosurgery released a position statement on the recommended use of MRI-guided laser interstitial therapy (MRgLITT) as first-line surgical therapy for various types of drug-resistant epilepsy (DRE). Epilepsy will…
Sleep disorders are associated with a range of comorbidities and a substantial impairment in quality of life. Sleep disorders may result from or affect the progression of neurologic diseases, such as Parkinson disease, and they…
Lipid metabolism is associated with the risk of developing amyotrophic lateral sclerosis (ALS), according to study results published in the Journal of Neurology, Neurosurgery, and Psychiatry. Premorbid metabolic profiles can provide insight into relevant biomarkers…
Sleep duration is a strong behavioral risk factor for mortality, with sleep durations ≥10 hours holding the greatest association with mortality for both men and women, suggests a study published in JAMA Network Open. The…
Boxing therapy may improve gait stability and reduce the risk for falls in patients with Parkinson disease (PD), according to study findings published in BMC Neurology. Motor impairment and gait instability in PD can increase…
Among infants with type 1 spinal muscular atrophy (SMA), treatment with risdiplam was associated with improvements in motor function and meeting developmental motor milestones, according to study results published in The New England Journal of…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021